Anixa Biosciences ANIX 深 沪
等待开盘 06-26 09:30:00 美东时间
2.635
-0.105
-3.83%
华盛通- 最 高2.97
- 今 开2.80
- 成交量 28.91万股
- 最 低 2.59
- 昨 收 2.74
- 总市值 8.03万
- 52周最高 5.4566
- 市盈率 静 --
- 换手率 948.93%
- 52周最低 2.32
- 委 比 -88.53%
- 总股本 3.05万
- 历史最高 8.09
- 量 比 1.16
- 振 幅 13.87%
- 历史最低 1.10
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Anixa Biosciences Q2 EPS $(0.07) Beats $(0.09) Estimate
Anixa Biosciences (NASDAQ:ANIX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 22.22 percent increase over losses of $(0.09) per share from
06-11 05:31
Anixa Biosciences Secures Canadian Patent Allowance For AMHR2-Targeting Ovarian Cancer Vaccine Technology
Allowed patent covers technology designed to elicit an AMHR2-specific immune response for the prevention or treatment of ovarian cancerSAN JOSE, Calif., June 1, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or
06-01 21:10
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
Douglas Love, president and CEO of Annexon, Inc., will present at the Jefferies Global Healthcare Conference on June 4, 2025. A live webcast and replay will be available on Annexon's website. The company focuses on developing therapies to treat neuroinflammatory diseases targeting the classical complement pathway.
2025-05-29 20:05
EF Hutton Maintains Buy on Anixa Biosciences, Maintains $10 Price Target
EF Hutton analyst Jason Kolbert maintains Anixa Biosciences (NASDAQ:ANIX) with a Buy and maintains $10 price target.
2024-09-09 23:54
